Home527005 › Filing
🔔 Get instant alerts when 527005 files quarterly results on BSE Start free trial →

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we wish to inform you that in the 02nd/2026-2027 meeting of the Board of Directors of ....

Filed: 13 Aug 2026, 17:23 IST Exchange: BSE Category: Management Change — Re-appointment of Directors
Board approved re-appointment of Mr. Akash Sethi as Joint Managing Director for 3 years from 14-Aug-2027 to 13-Aug-2030, subject to shareholder approval. - Ms. Manali Tongia re-appointed as Non-Executive Independent Director for 5 years from 24-Mar-2027 to 23-Mar-2032, subject to approval. - Ms. Somya Chhabra re-appointed as Non-Executive Independent Director for 5 years from 6-May-2027 to 5-May-2032, subject to approval. - All re-appointments recommended by Nomination and Remuneration Committee. - No SEBI disqualifications for appointees.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 527005 — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add 527005 to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Shree Pacetronix Ltd

Important. The summary above is generated automatically from Shree Pacetronix Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.